Highest-materiality recent filing
Cimpress completes acquisition of SAXOPRINT and viaprinto from CEWE
Acquisition of SAXOPRINT and viaprinto businesses from CEWE Stiftung & Co. KGaA completed on July 2, 2026.
Cimpress enters $1.1B Term Loan B and $250M revolver; refinances existing 2028 term loans
New $1.1B Term Loan B matures June 4, 2033; interest at SOFR + 2.50%, issued at 99.75% of par.
Cimpress to acquire SAXOPRINT & viaprinto for <€80M net cash; expected close H1 FY2027
Collective revenue of €89.6M in CY2025 with ~10% EBITDA margins; net cash outflow <€80M after asset sales.
Cimpress reports Q3 FY2026 financial results; no specific data in filing
Company posted its Q3 FY2026 Quarterly Earnings Document on April 29, 2026.
Cimpress board authorizes $200M share repurchase program, replacing prior authorization
Board authorized up to $200M in share repurchases on March 25, 2026, with no expiration date.
Cimpress Q2 revenue tops $1B for first time; raises FY2026 guidance
Revenue $1.042B, up 11% YoY; organic constant-currency up 4%. Adjusted EBITDA $138.8M, up 5%.
Robert S. Keane and Scott J. Vassalluzzo reappointed to Board for 3-year terms ending 2028.
Cimpress Q1 FY2026 revenue +7% to $863M, net income $6.5M vs loss; reaffirms FY guidance
Revenue $863M (+7% reported, +4% organic constant currency); operating income $49M (+$10M YoY).
Cimpress Q4 net loss of $28.4M, FY2025 adj. EBITDA down 8%; FY2026 outlook at least $450M
Q4 revenue $869.5M (+4% reported, +2% organic cc); net loss $28.4M vs income $118.2M prior year.
Cimpress appoints Lime CEO Wayne Ting to board of directors
Wayne Ting, CEO of Lime, appointed to Cimpress board effective May 27, 2025.
Cimpress Q3 revenue up 1% to $789M, net loss widens, guidance withdrawn on tariffs
Q3 revenue $789M (+1% reported, +3% organic constant currency); net loss $8.0M vs $5.2M loss a year ago.
Cimpress estimates annual tariff impact <$10M, cites exclusions and mitigation
Estimates <$10M annual direct tariff impact on imports from Canada, Mexico, and China before mitigation.
Cimpress Q2 adjusted EBITDA $132.3M (-21% YoY); lowers FY2025 outlook
Q2 revenue $939M (+2% reported, +2% organic CC); operating income $80.9M vs $107.7M.
Cimpress refinances Term Loan B; USD tranche rate cut 50 bps to SOFR+2.50%
Interest margin on USD tranche reduced from SOFR+3.00% to SOFR+2.50%.
Cimpress shareholders approve 2M share increase to equity incentive plan at AGM
Proposal to amend 2020 Plan passed: 17.3M for, 5.0M against (22% opposed, 1.8M broker non-votes).
Cimpress Q1 FY2025: revenue up 6% to $805M, net loss of $12.5M, adjusted EBITDA down 1%
Revenue $805M (+6% YoY); GAAP net loss $12.5M ($0.50 loss per share) vs net income $4.6M last year.
Cimpress issues $525M 7.375% Senior Notes due 2032 and amends credit facility
Issued $525M aggregate principal of 7.375% Senior Notes due September 15, 2032.
Cimpress prices $525M of 7.375% senior notes due 2032 to refinance existing 2026 notes
Offering of $525M aggregate principal of 7.375% senior notes due 2032 priced at 100% of par.
Cimpress launches $525M senior notes due 2032 to refinance 7.0% 2026 notes
Offering $525M aggregate principal of senior notes due 2032 in private placement.
Cimpress Q4 revenue $833M (+6% YoY); Adj. EBITDA $119M; FY2024 record revenue and EBITDA
Q4 revenue $832.6M (+6% YoY); operating income $66.3M (+$12.4M); Adj. EBITDA $119.4M (+$5.4M).
Cimpress board authorizes new $200M share repurchase program, completes $150M prior program
New authorization of up to $200M for open market or private repurchases, no expiration date.
Cimpress refinances Term Loan B, reduces margin 50 bps, expects $6M annual interest savings
Refinanced $773M USD Tranche and prepaid €245M of Euro Tranche via new $1.0375B USD Tranche.
Cimpress Q3 FY2024 revenue up 5%, adj EBITDA $94.2M, new net leverage target 2.5x
Revenue $780.6M (+5% reported, +4% organic CC); operating income $39.2M vs ($12.2M) YoY.
Cimpress Q2 revenue $921M, adj. EBITDA $166M; raises FY2024 guidance
Revenue $921.4M (+9% reported, +6% organic constant-currency); operating income $107.7M (up $74.1M YoY).
Cimpress shareholders reelect director, approve say-on-pay, renew share issuance authority
Shareholders reappointed Sophie S. Gasperment to the Board for a three-year term ending 2026.
Cimpress Q1 FY24 revenue up 8% to $757M; adj EBITDA $88.7M, 95% YoY growth; FY24 guidance raised
Revenue $757.3M (+8% reported, +4% organic CC); operating income $34.1M vs -$18.0M YoY.
Cimpress Q4 revenue $789M (+9% YoY); adj EBITDA $114M; guides FY24 EBITDA ≥$420M
Q4 revenue $788.8M (+9% reported, +9% organic constant currency); operating income $53.9M vs ($27.2M) a year ago.
Cimpress repurchases $51.7M of its 7% Senior Notes at ~13% discount
Purchased $51.7M notional of 7.0% Senior Notes due 2026 for $44.994M (excl. accrued interest).
Cimpress Q3 FY2023 earnings released; no specific figures in filing excerpt
Filing states earnings document posted on website on April 26, 2023.
Cimpress cuts 500 jobs, expects $100M annual savings; pre-tax charge of $25-27M
Board approved ~500 role reductions at Vista and central teams; majority communicated March 21.
Cimpress signs retention agreements with four executives; no material change to prior deals
Agreements dated Feb 20, 2023 cover CEO Keane, CFO Quinn, CTO Wensveen (amended/restated) and Vista CEO Baumgartner (new).
Cimpress reports Q2 FY2023 results; filing exhibit lacks financial data
Company posted Q2 FY2023 earnings document on January 25, 2023 for quarter ended Dec 31, 2022.
Cimpress shareholders approve 2M share increase in equity plan at 2022 AGM
Shareholders approved amendment to 2020 Equity Incentive Plan, increasing authorized shares by 2,000,000 to 5,500,000.
Cimpress posts Q1 FY2023 results; specific figures not available in filing extract
Filed earnings document for Q1 ended September 30, 2022, on October 26, 2022.
Cimpress releases Q4 FY2022 earnings; specific figures not in provided text
Company reported results for fiscal quarter and year ended June 30, 2022.
Cimpress plc Reports Q3 Fiscal Year 2022 Financial Results
Financial results for the quarter ended March 31, 2022 were posted on the company's website on April 27, 2022.
Cimpress reports Q2 FY2022 results but specific figures not available in filing text
Filing includes Exhibit 99.1 which is a table of contents only; no financial data provided.
Shareholders reappointed Zachary S. Sternberg to the board for a three-year term (21.5M for, 2.5M against).
Cimpress releases Q1 FY2022 earnings document; no specific figures in provided excerpt
Filed 8-K for Q1 FY2022 results for quarter ended September 30, 2021.
Cimpress appoints Dessislava Temperley to Board; John Gavin to retire
Dessislava Temperley appointed to Board effective Sept 15, 2021, term through 2024 AGM.
Cimpress's Vistaprint partners with Wix to power online presence for 17M+ small biz customers
Vistaprint selects Wix as preferred technology layer for websites and e-commerce for its 17M+ customers.
Cimpress posts Q4 & FY2021 results; specific financials not provided in excerpt
Results cover fiscal quarter and year ended June 30, 2021.
On May 27, 2025, the Board of Directors of Cimpress plc (the “Company”) appointed Wayne Ting to the Board to serve for a term of approximately two and a half years ending at the conclusion of the Company’s annual general meeting of shareholders in 2027.
On September 15, 2021, the Board of Directors of Cimpress plc appointed Dessislava Temperley to the Board to serve for a term of three years ending at the conclusion of Cimpress' annual general meeting of shareholders in 2024.
Max materiality 0.90 · Median 0.57 · Most common event earnings